Although mortality is less, two recent reports indicate that contemporary characterization of children with sepsis may be insufficient (11, 12). In one study, protocolized fluid boluses such as those commonly recommended in the developed world increased mortality compared with usual care by local practitioners (11). In the other study, protocolized fluid regimens appeared to increase mortality in children with concomitant respiratory failure (12). The reasons for these unfortunate outcomes are not understood, but it is precisely that knowledge gap (and its consequences) that should direct us away from consensus-type definitions of fatal illness and point us instead toward placing our patients on the potentially firmer footing of biologic insight.In summary, the big lesson from the paper by Wong and colleagues is that biologic insights into how (and who) septic shock can kill might soon be applied to the advantage of individual patients (1). In an age of consensus, guidelines, and big data, it is easy to forget that the biology of the individual patient matters; important work such as this reminds us that in pediatric septic shock, it almost certainly does. n Author disclosures are available with the text of this article at www.atsjournals.org.